HOUSE_OVERSIGHT_024763.jpg
1.44 MB
Extraction Summary
1
People
10
Organizations
2
Locations
3
Events
2
Relationships
2
Quotes
Document Information
Type:
Financial report / investment analysis
File Size:
1.44 MB
Summary
This document is page 127 of a report by Ackrell Capital titled 'Capital Markets for Cannabis Companies.' It provides a financial summary of Canadian publicly traded cannabis-related companies as of November 30, 2017, including market value and revenue data for companies on the TSX, TSXV, and CSE. The text also references the positive market impact of Prime Minister Justin Trudeau's legislative announcements and an investment by Constellation Brands into Canopy Growth. The document bears a 'HOUSE_OVERSIGHT' Bates stamp.
People (1)
| Name | Role | Context |
|---|---|---|
| Justin Trudeau | Prime Minister |
Mentioned regarding the announcement of proposed recreational cannabis legislation in Canada.
|
Organizations (10)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Investment bank/firm producing the report.
|
|
| Toronto Stock Exchange (TSX) |
Listed as a market for cannabis companies.
|
|
| TSX Venture Exchange (TSXV) |
Listed as a market for cannabis companies.
|
|
| Canadian Securities Exchange (CSE) |
Listed as a market for cannabis companies.
|
|
| S&P Global Market Intelligence |
Source for the financial table provided.
|
|
| Constellation Brands |
Mentioned for its investment in Canopy Growth.
|
|
| Canopy Growth |
Received investment from Constellation Brands.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT'.
|
|
| FINRA |
Ackrell Capital is a member.
|
|
| SIPC |
Ackrell Capital is a member.
|
Timeline (3 events)
Locations (2)
| Location | Context |
|---|---|
|
Primary market discussed.
|
|
|
Mentioned that some CSE companies have operations here.
|
Relationships (2)
Announcement of proposed recreational cannabis legislation.
Constellation Brands’ investment in Canopy Growth.
Key Quotes (2)
"As of November 30, 2017, six cannabis-related companies were trading on the TSX, 20 were trading on the TSXV and 41 were trading on the CSE."Source
HOUSE_OVERSIGHT_024763.jpg
Quote #1
"The chart indicates that the stock price performance of cannabis-related companies trading on Canadian markets received a boost from the announcement of the proposed recreational cannabis legislation in Canada by Prime Minister Justin Trudeau and, more recently, from Constellation Brands’ investment in Canopy Growth."Source
HOUSE_OVERSIGHT_024763.jpg
Quote #2
Full Extracted Text
Complete text extracted from the document (2,195 characters)
ACKRELL
CAPITAL
CHAPTER VII Capital Markets for Cannabis Companies
CAPITAL
CHAPTER VII Capital Markets for Cannabis Companies
■ Public Capital Markets: Canada
As of November 30, 2017, six cannabis-related companies were trading on the TSX, 20 were trading on the TSXV and 41 were trading on the CSE. Most of the publicly traded cannabis-related companies in Canada are licensed producers under Canada’s Access to Cannabis for Medical Purposes Regulations, which allow a company to produce and sell medical cannabis products in Canada. A number of companies traded on the CSE also have cannabis-related operations in the United States. The following table provides a summary of cannabis-related companies traded on Canadian stock markets.
As of November 30, 2017, six cannabis-related companies were trading on the TSX, 20 were trading on the TSXV and 41 were trading on the CSE. Most of the publicly traded cannabis-related companies in Canada are licensed producers under Canada’s Access to Cannabis for Medical Purposes Regulations, which allow a company to produce and sell medical cannabis products in Canada. A number of companies traded on the CSE also have cannabis-related operations in the United States. The following table provides a summary of cannabis-related companies traded on Canadian stock markets.
Summary of Canadian Publicly Traded Cannabis-Related Companies
(As of November 30, 2017)
Average ($U.S. millions)
Number of Companies
Market Value
Enterprise Value
Cash
Debt
LTM Revenue
LTM EBITDA
Average ($U.S. millions)
Number of Companies
Market Value
Enterprise Value
Cash
Debt
LTM Revenue
LTM EBITDA
Toronto Stock Exchange (TSX) 6 $1,361.5 $1,311.4 $71.0 $20.8 $26.6 $0.8
TSX Venture Exchange (TSXV) 20 131.5 123.9 10.8 3.3 1.2 –3.5
Canadian Securities Exchange (CSE) 41 72.6 72.0 2.0 1.4 1.8 –2.8
Canada 67 $210.6 $203.3 $11.1 $3.8 $4.0 –$2.2
TSX Venture Exchange (TSXV) 20 131.5 123.9 10.8 3.3 1.2 –3.5
Canadian Securities Exchange (CSE) 41 72.6 72.0 2.0 1.4 1.8 –2.8
Canada 67 $210.6 $203.3 $11.1 $3.8 $4.0 –$2.2
Source: S&P Global Market Intelligence. Companies that are traded on more than one market are included in their primary market as determined by S&P Global Market Intelligence, based on stock price history, trading volume and availability of estimates. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation and Amortization.
Stock Price Performance of Canadian
Publicly Traded Cannabis-Related Companies
The following chart shows the stock price performance of selected publicly traded cannabis-related companies in Canada since September 30, 2016. The chart indicates that the stock price performance of cannabis-related companies trading on Canadian markets received a boost from the announcement of the proposed recreational cannabis legislation in Canada by Prime Minister Justin Trudeau and, more recently, from Constellation Brands’ investment in Canopy Growth.
Publicly Traded Cannabis-Related Companies
The following chart shows the stock price performance of selected publicly traded cannabis-related companies in Canada since September 30, 2016. The chart indicates that the stock price performance of cannabis-related companies trading on Canadian markets received a boost from the announcement of the proposed recreational cannabis legislation in Canada by Prime Minister Justin Trudeau and, more recently, from Constellation Brands’ investment in Canopy Growth.
© 2017 Ackrell Capital, LLC | Member FINRA/SIPC
127
HOUSE_OVERSIGHT_024763
127
HOUSE_OVERSIGHT_024763
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document